Uncategorised - European Medical Journal

Is Early-Stage Melanoma Recurrence Predictable with Artificial Intelligence?

Researchers from Massachusetts General Hospital (MGH), Boston, USA, have developed a novel way of predicting which patients with melanoma are more likely to experience a recurrence with artificial intelligence.

Breast Milk Might Protect Infants from Atopic Dermatitis

According to research, breastfed babies are less likely to develop conditions such as atopic dermatitis, food allergies, and wheezing than babies fed with formula. Read to find out more.

Using Artificial Intelligence for Early Pneumonia Diagnosis

Cough sounds could be utilised by machine learning algorithms to identify whether an individual has pneumonia. Read to find out more…

Should Post-Lung Cancer Surgery Surveillance Imaging Guidelines Be Amended?

According to new research, the guidelines of post-surgical surveillance imaging for early-stage NSCLC may recommend it too frequently…

Improving Overall Survival for Patients with Pancreatic Cancer

Chemotherapy treatment before and after pancreatic cancer surgery is the most effective combination for patients. Read more

Prostate Cancer Risk Predictable Through Family History and Genes

A team of researchers have developed CanRisk-Prostate, which will be incorporated into CanRisk, a tool for cancer risk predictions.

Turning patient insights into action

Pharma endeavours to drive positive action from patient insights. Read to find out how they could improve their methodologies and outcomes.

Using Behavioral Science to Help Understand Vaccine Hesitancy

This video details Graves’ research on vaccine hesitancy and the psychological and sociocultural factors behind it. Learn ways to identify and overcome vaccine hesitancy by using valuable, research-based insights and strategies.

Mitigating the rare disease RWD deficit

RWD for rare diseases is scarce, but pharma can work to leverage existing processes and build trust to enhance the scope of available data.

Sales reps, MSLs and the future of CX

In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.